Healthcare provider profile · identity verified

Soroush Behnam, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · DALLAS, TX · NPI 1710908744

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Soroush Behnam, MD received $15.08 in general payments during 2025 across 1 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Linzess.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Lumigan by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$15.08

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$15.08	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$15.08	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
CREON Normalized: creon	Drug	ABBVIE INC.	$15.08	1	2025
Source payment records 2025-02-24 · ABBVIE INC. · $15.08 · Open Payments source
LINZESS Normalized: linzess	Drug	ABBVIE INC.	$15.08	1	2025
Source payment records 2025-02-24 · ABBVIE INC. · $15.08 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
LINZESS linzess	2025	Linzess	2024	17 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LUMIGAN open payments reported associated product	CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548	Lumigan · 2024 Exact normalized brand match · 1 Part D row	15	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1326	227
Atorvastatin Calcium	Atorvastatin Calcium	1151	300
Eliquis	Apixaban	962	186
Amlodipine Besylate	Amlodipine Besylate	941	240
Furosemide	Furosemide	870	200
Gabapentin	Gabapentin	756	200
Tamsulosin Hcl	Tamsulosin Hcl	553	131
Donepezil Hcl	Donepezil Hcl	540	101
Potassium Chloride	Potassium Chloride	515	151
Metoprolol Tartrate	Metoprolol Tartrate	489	118
Lisinopril	Lisinopril	487	120
Pantoprazole Sodium	Pantoprazole Sodium	481	121
Trazodone Hcl	Trazodone Hcl	458	93
Memantine Hcl	Memantine Hcl	446	80
Mirtazapine	Mirtazapine	408	100
Escitalopram Oxalate	Escitalopram Oxalate	388	77
Losartan Potassium	Losartan Potassium	387	120
Clopidogrel	Clopidogrel Bisulfate	363	84
Metoprolol Succinate	Metoprolol Succinate	358	114
Omeprazole	Omeprazole	350	139
Sertraline Hcl	Sertraline Hcl	343	85
Carvedilol	Carvedilol	331	109
Metformin Hcl	Metformin Hcl	317	85
Buspirone Hcl	Buspirone Hcl	301	70
Hydralazine Hcl	Hydralazine Hcl	270	72
Levetiracetam	Levetiracetam	262	49
Duloxetine Hcl	Duloxetine Hcl	260	64
Divalproex Sodium	Divalproex Sodium	256	47
Fluoxetine Hcl	Fluoxetine Hcl	231	36
Rosuvastatin Calcium	Rosuvastatin Calcium	226	51
Tramadol Hcl	Tramadol Hcl	213	81
Citalopram Hbr	Citalopram Hydrobromide	190	45
Famotidine	Famotidine	176	60
Latanoprost	Latanoprost	170	45
Pravastatin Sodium	Pravastatin Sodium	168	50
Fluticasone Propionate	Fluticasone Propionate	166	72
Methocarbamol	Methocarbamol	165	81
Montelukast Sodium	Montelukast Sodium	164	60
Ropinirole Hcl	Ropinirole Hcl	163	32
Acetaminophen-Codeine	Acetaminophen With Codeine	156	39
Amiodarone Hcl	Amiodarone Hcl	154	48
Spironolactone	Spironolactone	149	48
Simvastatin	Simvastatin	141	36
Midodrine Hcl	Midodrine Hcl	135	41
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	131	92
Alendronate Sodium	Alendronate Sodium	126	35
Xarelto	Rivaroxaban	126	25
Ondansetron Hcl	Ondansetron Hcl	123	85
Insulin Lispro Kwikpen U-100	Insulin Lispro	119	47
Alprazolam	Alprazolam	118	42
Pregabalin	Pregabalin	118	46
Finasteride	Finasteride	117	34
Bupropion Xl	Bupropion Hcl	114	29
Esomeprazole Magnesium	Esomeprazole Magnesium	114	18
Prednisone	Prednisone	111	44
Glipizide	Glipizide	110	24
Myrbetriq	Mirabegron	110	14
Allopurinol	Allopurinol	106	34
Oxybutynin Chloride	Oxybutynin Chloride	106	24
Oxybutynin Chloride Er	Oxybutynin Chloride	101	23
Torsemide	Torsemide	99	26
Zolpidem Tartrate	Zolpidem Tartrate	98	23
Cefuroxime	Cefuroxime Axetil	97	67
Baclofen	Baclofen	95	21
Jardiance	Empagliflozin	94	32
Clonidine Hcl	Clonidine Hcl	89	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	34
Quetiapine Fumarate	Quetiapine Fumarate	86	28
Lactulose	Lactulose	81	19
Sucralfate	Sucralfate	78	24
Carbidopa-Levodopa	Carbidopa/Levodopa	77	20
Nifedipine Er	Nifedipine	76	20
Lorazepam	Lorazepam	75	27
Doxycycline Hyclate	Doxycycline Hyclate	73	48
Ezetimibe	Ezetimibe	73	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	53
Azithromycin	Azithromycin	72	47
Isosorbide Mononitrate Er	Isosorbide Mononitrate	72	28
Clonazepam	Clonazepam	71	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	68	suppressed
Ondansetron Odt	Ondansetron	67	46
Solifenacin Succinate	Solifenacin Succinate	65	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	28
Hydroxyzine Hcl	Hydroxyzine Hcl	64	23
Timolol Maleate	Timolol Maleate	64	15
Meloxicam	Meloxicam	62	18
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	61	29
Lubiprostone	Lubiprostone	61	suppressed
Nystatin	Nystatin	61	32
Vitamin D2	Ergocalciferol (Vitamin D2)	61	23
Dicyclomine Hcl	Dicyclomine Hcl	60	16
Levofloxacin	Levofloxacin	60	37
Hydrochlorothiazide	Hydrochlorothiazide	58	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	58	42
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	39
Lovastatin	Lovastatin	55	14
Januvia	Sitagliptin Phosphate	53	suppressed
Risperidone	Risperidone	53	14
Triamcinolone Acetonide	Triamcinolone Acetonide	52	23
Rivastigmine	Rivastigmine Tartrate	51	suppressed
Warfarin Sodium	Warfarin Sodium	51	12
Albuterol Sulfate Hfa	Albuterol Sulfate	50	44
Aripiprazole	Aripiprazole	50	12
Propranolol Hcl	Propranolol Hcl	48	suppressed
Digoxin	Digoxin	47	11
Enoxaparin Sodium	Enoxaparin Sodium	47	25
Topiramate	Topiramate	47	suppressed
Bupropion Hcl Sr	Bupropion Hcl	46	15
Nitroglycerin	Nitroglycerin	45	38
Xifaxan	Rifaximin	45	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Humalog	Insulin Lispro	43	13
Budesonide	Budesonide	42	18
Atenolol	Atenolol	41	13
Hydrocortisone	Hydrocortisone	41	11
Olanzapine	Olanzapine	41	11
Entresto	Sacubitril/Valsartan	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	13
Albuterol Sulfate	Albuterol Sulfate	39	21
Humalog Kwikpen U-100	Insulin Lispro	39	24
Enulose	Lactulose	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	17
Trulicity	Dulaglutide	38	suppressed
Bupropion Hcl	Bupropion Hcl	37	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	suppressed
Folic Acid	Folic Acid	36	15
Methenamine Hippurate	Methenamine Hippurate	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	21
Lacosamide	Lacosamide	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	12
Azelastine Hcl	Azelastine Hcl	34	suppressed
Sodium Chloride	0.9 % Sodium Chloride	34	29
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Primidone	Primidone	33	suppressed
Rytary	Carbidopa/Levodopa	33	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	15
Bumetanide	Bumetanide	31	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	30	suppressed
Methimazole	Methimazole	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Glimepiride	Glimepiride	29	11
Metformin Hcl Er	Metformin Hcl	29	suppressed
Rivastigmine	Rivastigmine	29	suppressed
Scopolamine	Scopolamine	29	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	suppressed
Flecainide Acetate	Flecainide Acetate	28	suppressed
Insulin Lispro	Insulin Lispro	28	11
Levemir Flexpen	Insulin Detemir	28	12
Metronidazole	Metronidazole	28	suppressed
Nystop	Nystatin	28	21
Benazepril Hcl	Benazepril Hcl	27	suppressed
Cephalexin	Cephalexin	27	16
Fycompa	Perampanel	27	suppressed
Santyl	Collagenase Clostridium Hist.	27	17
Brimonidine Tartrate	Brimonidine Tartrate	26	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	15
Lansoprazole	Lansoprazole	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Calcitriol	Calcitriol	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Levemir	Insulin Detemir	24	suppressed
Valsartan	Valsartan	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	24	suppressed
Clotrimazole	Clotrimazole	23	12
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	16
Synjardy	Empagliflozin/Metformin Hcl	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	17
Fluorometholone	Fluorometholone	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	16
Nuplazid	Pimavanserin Tartrate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Ceftriaxone	Ceftriaxone Sodium	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Oxcarbazepine	Oxcarbazepine	21	suppressed
Ranolazine Er	Ranolazine	21	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	13
Clonidine	Clonidine	20	suppressed
Estradiol	Estradiol	20	suppressed
Fluconazole	Fluconazole	20	14
Modafinil	Modafinil	20	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Cefdinir	Cefdinir	19	14
Dorzolamide Hcl	Dorzolamide Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Movantik	Naloxegol Oxalate	19	suppressed
Novolog	Insulin Aspart	19	suppressed
Ramipril	Ramipril	19	suppressed
Azathioprine	Azathioprine	18	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	18	suppressed
Mupirocin	Mupirocin	18	15
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Voriconazole	Voriconazole	18	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	17	suppressed
Cyclosporine	Cyclosporine	17	suppressed
Gemtesa	Vibegron	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lidocaine	Lidocaine	17	11
Linzess	Linaclotide	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Tradjenta	Linagliptin	17	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Permethrin	Permethrin	15	suppressed
Rexulti	Brexpiprazole	15	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Anastrozole	Anastrozole	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Amoxicillin	Amoxicillin	13	11
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Brinzolamide	Brinzolamide	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Temazepam	Temazepam	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dimethyl Fumarate	Dimethyl Fumarate	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Meropenem	Meropenem	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$15.08 · 1 records	ABBVIE INC.	CREON, LINZESS	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Linzess play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error